News
Moderna's New Lower-Dose COVID-19 Vaccine Approved by FDA
By Stephanie Brown HealthDay ReporterTUESDAY, June 3, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
The owners of an Alma gym argued they should be paid for losses during Gov. Whitmer's COVID-19 closure orders.
1don MSN
Rep. Marjorie Taylor Greene slams FDA green lighting of Moderna's mNEXSPIKE COVID-19 vaccine, describing the move as "Not ...
The US Centers for Disease Control and Prevention has updated its immunization schedule for children, days after US Health ...
Daily News on MSN2h
No new strain of COVID-19 found in SL - Dr. JasingheNovel variants of SARS-CoV-2 virus that cause COVID-19 disease have not been detected in Sri Lanka, Health Ministry Secretary ...
Symptoms appear to be similar to other variants of COVID-19 and the public health risk remains low, WHO information shows.
The US Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., has recently made significant changes ...
The Centers for Disease Control and Prevention now says that kids with no underlying health conditions "may receive" COVID-19 ...
The Department of Health and Human Services announced it is shuttering a nationwide program that offered free COVID-19 tests ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback